Busch Andreas 4
4 · Cyclerion Therapeutics, Inc. · Filed Jan 24, 2022
Insider Transaction Report
Form 4
Busch Andreas
Chief Innovation Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2022-01-20+135,000→ 135,000 totalExercise: $1.21Exp: 2032-01-20→ Common Stock (135,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 20, 2022.